Left to Right: NCPA President Bill Osborn,PharmD; Steve Moore, PharmD (winner); and Mike McBride of Upsher Smith
NCPA AWARD SPONSORED BY UPSHER-SMITH FOR ELEVENTH CONSECUTIVE YEAR
Maple Grove, MN – October 29, 2019 – Upsher-Smith Laboratories, LLC ... Read More
VISIT BOOTH #414 TO LEARN ABOUT VIGADRONE® (VIGABATRIN) FOR ORAL SOLUTION AND ITS SAVINGS AND SUPPORT PROGRAM
Maple Grove, MN – October 22, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending ... Read More
DELIVERS THE EFFICACY OF AN INJECTABLE WITH THE CONVENIENCE OF A NASAL SPRAY
Maple Grove, MN – October 2, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith)today announced the launch of Tosymra™ (sumatriptan) Nasal Spray, 10 mg for ... Read More
Maple Grove, MN – September 20, 2019 – UpsherSmith Laboratories, LLC (Upsher-Smith) today announced that executives from its parent company, Sawai Pharmaceutical Co., Ltd. (Sawai) including Sawai’s President, Mitsuo Sawai and General Manager of External ... Read More
Osaka, Japan – August 28, 2019 – Sawai Pharmaceutical Co., Ltd. (Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of its partial change application by the Ministry of Health, Labour and Welfare (MHLW) ... Read More
Maple Grove, MN – August 27, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Morphine Sulfate Tablets, CII, 15 and 30 mg. The morphine sulfate tablet market had U.S. sales of approximately ... Read More
Osaka, Japan – August 15, 2019 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approvals by the Ministry of Health, Labour and Welfare for two generic drugs with five strengths. The two compounds, Aprepitant and Micafungin Sodium are approved for the first time ... Read More
